Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients

Sponsor
University of Michigan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05410561
Collaborator
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
300
1
2
35
8.6

Study Details

Study Description

Brief Summary

The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting.

This research will take place remotely (e.g., Zoom, Facetime, Phone) and participants will be randomized to the Telehealth (TeleTx) group intervention or the Enhanced Usual Care (EUC) control group. Both groups will be asked to have follow-up visits up to 12 months from the baseline visit.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Enhanced Usual Care (EUC)
  • Behavioral: TeleTx intervention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
Anticipated Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: TeleTx intervention

The evidence-based manualized psychosocial program is via telehealth and uses adaptations of cognitive behavioral therapy and motivational interviewing.

Behavioral: TeleTx intervention
TeleTx will consist of an initial session and then 8 ~counseling sessions.

Active Comparator: Enhanced Usual Care (EUC)

EUC will include brief psychoeducation about AUD and resources for treatment.

Behavioral: Enhanced Usual Care (EUC)
EUC will comprise one session of brief psychoeducation and referral information to alcohol use disorder (AUD) treatment.

Outcome Measures

Primary Outcome Measures

  1. Alcohol Use Disorder Treatment Initiation [3 months]

    Percent of patients who initiate Alcohol Use Disorder psychotherapy treatment

  2. Alcohol Use Disorder Treatment Engagement [3 months]

    Percent of patients who attend at least 2 additional Alcohol Use Disorder psychotherapy sessions

  3. Alcohol consumption days [3-months]

    Percent days of alcohol use on the Timeline Follow Back interview

  4. Alcohol consumption days [6-months]

    Percent days of alcohol use on the Timeline Follow Back interview

  5. Alcohol consumption days [12-months]

    Percent days of alcohol use on the Timeline Follow Back interview

  6. Heavy drinking days [3-months]

    Percent days heavy drinking on the Timeline Follow Back interview

  7. Heavy drinking days [6-months]

    Percent days heavy drinking on the Timeline Follow Back interview

  8. Heavy drinking days [12-months]

    Percent days heavy drinking on the Timeline Follow Back interview

Secondary Outcome Measures

  1. Total Alcohol Use Disorder Psychotherapy Treatment Attendance [6-months]

    Total number of psychotherapy sessions

  2. Total Alcohol Use Disorder Psychotherapy Treatment Attendance [12-months]

    Total number of psychotherapy sessions

  3. Drinking Risk Levels (Based on World Health Organization Cut-Offs) [Baseline to 3-months]

    Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes)

  4. Drinking Risk Levels (Based on World Health Organization Cut-Offs) [Baseline to 6-months]

    Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes)

  5. Drinking Risk Levels (Based on World Health Organization Cut-Offs) [Baseline to 12-months]

    Change in WHO drinking levels (defined by alcohol consumed per day from 1g to undefined maximum with higher amounts associated with worse outcomes)

  6. World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) [Baseline to 3-months]

    Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life.

  7. World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) [Baseline to 6-months]

    Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life.

  8. World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF) [Baseline to 12-months]

    Change in Quality of Life measure (WHO-QOL BREF). Transformed domain scores from 0 to 100. Higher scores denote better quality of life.

  9. Alcohol consequences [Baseline to 3-months]

    Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R

  10. Alcohol consequences [Baseline to 6-months]

    Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R

  11. Alcohol consequences [Baseline to 12-months]

    Change in alcohol consequences measured by the modified 17-item Short Inventory of Problem-R

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Current Diagnostic and Statistical Manual (DSM) -5 alcohol use disorder (AUD) based on alcohol symptom checklist

  • An average of 3 or more drinking days per week for the past 30 days

  • Have regular access to a device with video capabilities or a phone to use for study related calls

Exclusion Criteria:
  • Inability to speak or understand English

  • Conditions that preclude informed consent or understanding of assessment or intervention content

  • Past 90-day AUD psychotherapy treatment,

  • At elevated risk for complicated alcohol withdrawal

  • Past-year drug injection.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Investigators

  • Principal Investigator: Allison Lin, MD, University of Michigan
  • Principal Investigator: Erin Bonar, PhD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Allison Lin, Assistant Professor of Psychiatry, University of Michigan
ClinicalTrials.gov Identifier:
NCT05410561
Other Study ID Numbers:
  • HUM00204315
  • 1R01AA029400-01
First Posted:
Jun 8, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Allison Lin, Assistant Professor of Psychiatry, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022